Transcript ALL RESEARCH TOPICS WERE OPEN FOR 3rd

International Collaboration
in FP7
Health Research
Outcome of FP6
Reminder:
ALL RESEARCH TOPICS WERE OPEN FOR 3rd
COUNTRY PARTICIPANTS
• At least 3 organizations from EU and/or
associated states
• In addition, “third country” participants
were welcome
• Partners from the INCO target countries,
could receive funding
SIXTH FRAMEWORK PROGRAMME 2002-2006
Participation by legal entities from third countries
European Union/
Associated States (1)/
Overseas Countries & Territories
Target countries of specific measures in
support of international cooperation:
eligible for participation and funding
(within limits of budget)
Other third countries: eligible for
participation; funding if provision under
RTD activity or essential for carrying out
indirect action
Currently no cooperation
1
3rd countries’
participation in FP6
Health Research
Number of 3rd country participants in Health projects
U
SA
C
hi
na
R
So u
ut ssi
h
a
Af
Au rica
st
Ar ral
ge ia
nt
C ina
an
ad
a
In
di
Br a
az
Ke il
ny
a
Number of
participants
(Top Ten)
35
30
25
20
15
10
5
0
In total: 245 participants
from 51 third countries
Timeframe
for FP7 projects
Results from FP7 projects in use
Projects resulting from FP7 calls operating
Official duration of FP7 2007-2013
2006
2007
First calls
2008
2009
2010
First projects
start
2011
2012
2013
2014
2015 2016
Last projects start
2017
2018
2019
2020
Last projects end
2021
Health Research
Rationale for pan-European approach
– Strong EU-based biomedical research
strengthen the competitiveness of large industries
(pharma) and SMEs (healthcare biotech & medical
technology)
• Transnational co-operation is essential to face the
worldwide competition
• Contribute to the development of norms & standards to
set up appropriate legislative framework for new
medical technologies (e.g. regenerative medicine)
International Collaboration
Issues at stake
A) Development assistance
policy objectives, e.g. Millennium Development Goals
targets: poor countries, e.g. ACP
B) Strengthening EU competitiveness
competing with industrialised countries (e.g. attracting excellence)
collaboration for mutual gains
targets: more developed countries (e.g. BRIC)
C) Science diplomacy
collaborating with industrialised countries
“ice breaking” when collaborating with new partner countries
putting “meat on the bones” of S+T agreements
a sign of maturity of the FPs (openness)
targets: OECD, all 3rd countries
International Collaboration
Target countries/regions
MS/Ac – EU-Member States/Associated Countries
+
ICPC – International Cooperation Partner Countries
EECA – Eastern Europe and Central Asia
ACP – African, Carribean and Pacific Countries
MCP – Mediterranean Partner Countries
BRIC – Brazil, Russia, India and China
WB – Western Balkan
or other: Latin America, Asia, …
International Collaboration
What is new in FP7?
The management of thematic INCO projects
moves from the INCO directorate to the
thematic directorates
 INCO-Health to Health Research
- better synergies with traditional collaborative
projects in the theme
- greater visibility for INCO projects as part of a
larger portfolio
International Collaboration
in FP7
2 different avenues:
1. All activities open for International Cooperation
 International Cooperation Partner Countries (ICPCs) can
participate in projects and receive EC funding
 Minimum number of participants: 3 from MS/AS
 2. Specific International Cooperation Actions - SICA
 Address specific issues of partner countries or with a global
character, on the basis of mutual interest and benefit
 Minimum number of participants: 2+2
(2 from MS/AS + 2 from ICPCs)
International Collaboration
in FP7 Health
15 SICA topics in the first Work Programme
(deadlines in 2007)
Examples
• Influenza research with Asian partners
• Childhood and adolescent mental disorders (EECA
and Western Balkans)
• Development of new diagnostic and therapeutic
tools to confront infectious agents of the
Trypanosomatidae family (ICPC)
• Bioprospecting for drug leads – to find new drugs
against infectious diseases (ICPC)
• Improving Pre-natal and maternal care (ACP, MPC)
International Collaboration
in FP7 Health
15 SICA topics in the first Work Programme
(deadlines in 2007)
Examples cont.:
• Traditional Chinese medicine (China)
• Innovative research in HIV/AIDS, malaria, TB (India)
• Epidemiological investigations into long-term trends
of population health… (MPC, Russia and EECA)
• Health care intervention research (Western Balkans)
• Next generation of researchers for HIV/AIDS,
malaria, TB and neglected infectious diseases
(ICPC)
Information
• Dr. Indridi Benediktsson
Directorate Health, Horizontal Aspects and
Coordination
[email protected]
• Information requests
http://ec.europa.eu/research/index.cfm?pg=enquiries